New application of a subcellular fractionation method to kidney and testis for the determination of conjugated linoleic acid in selected cell organelles of healthy and cancerous human tissues

Hoffmann, Kristina; Blaudszun, Jörg; Brunken, Claus; Höpker, Wilhelm-Wolfgang; Tauber, Roland; Steinhart, Hans
March 2005
Analytical & Bioanalytical Chemistry;Mar2005, Vol. 381 Issue 6, p1138
Academic Journal
To clarify the mechanism of the anticarcinogenic effect of conjugated linoleic acid (CLA), its intracellular distribution needs to be determined. Subcellular fractionation using centrifugation techniques is a method that is frequently used for isolation of cell organelles from different tissues. But as the size and density of the organelles differ, the method needs to be optimised for every type of tissue. The novelty of this study is the application of a subcellular fractionation method to human healthy and cancerous renal and testicular tissue. Separation of total tissue homogenate into nuclei, cytosol, and a mixture of mitochondria and plasma membranes was achieved by differential centrifugation. As mitochondria and plasma membranes seemed to be too similar in size and weight to be separated by differential centrifugation, discontinuous density-gradient centrifugation was carried out successfully. The purity of the subcellular fractions was checked by measuring the activity of marker enzymes. All fractions were highly enriched in their corresponding marker enzyme. However, the nuclear fractions of kidney and renal cell carcinoma were slightly contaminated with mitochondria and plasma membrane fractions of all tissues with lysosomes. The fraction designated the cytosolic fraction contained not only cytosol, but also microsomes and lysosomes. The CLA contents of the subcellular fractions were in the range 0.13-0.37% of total fatty acids and were lowest in the plasma membrane fractions of all types of tissue studied. C16:0, C18:0, C18:1 c9, C18:2 n-6, and C20:4 n-6 were found to be the major fatty acids in all the subcellular fractions studied. However, marked variations in fatty acid content between subcellular fractions and between types of tissue were detectable. Because of these differences between tissues, no general statement on characteristic fatty acid profiles of single subcellular fractions is possible.


Related Articles

  • Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells. Walczak, Katarzyna; Żurawska, Małgorzata; Kiś, Jacek; Starownik, Radosław; Zgrajka, Wojciech; Bar, Krzysztof; Turski, Waldemar; Rzeski, Wojciech // Amino Acids;Oct2012, Vol. 43 Issue 4, p1663 

    Kidneys possess a complex enzyme system which plays a major role in tryptophan metabolism. Taking into account a considerably high concentration of one of the tryptophan metabolites, kynurenic acid (KYNA) in this organ and previously reported antiproliferative activity against colon cancer cells...

  • Quantitative changes within the peripheral blood CD8highCD57+ T-cell subpopulation of patients with advanced renal cell carcinoma. Strioga, Marius; Pašukonienė, Vita; Dobrovolskienė, Neringa; Petraitis, Tadas; Kazlauskaite, Nijole; Darinskas, Adas; Jokubauskiene, Lina; Characiejus, Dainius // Acta Medica Lituanica;2013, Vol. 20 Issue 4, p147 

    Background. Antitumor immunotherapy strategies, such as cytokinebased or cell-based immunotherapies, are designed to activate immune response against cancer cells, but considering that malignancy may be associated with the expansion of immunosuppressive components of antitumor immunity, it is...

  • Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C. Yi Zhi; Jin Yang; Shengchao Tian; Fang Yuan; Yang Liu; Yi Zhang; Pinghua Sun; Bo Song; Zhiwen Chen // International Journal of Molecular Sciences;May2012, Vol. 13 Issue 5, p6009 

    Topoisomerase I is important for DNA replication and cell division, making it an attractive drug target for anticancer therapy. A series of indenoisoquinolines displaying potent Top1 inhibitory activity in human renal cell carcinoma cell line SN12C were selected to establish 3D-QSAR models using...

  • Identification of the Δ-6 Desaturase of Human Sebaceous Glands: Expression and Enzyme Activity. Ge, Lan; Gordon, Joel S.; Hsuan, Charleen; Stenn, Kurt; Prouty, Stephen M. // Journal of Investigative Dermatology;May2003, Vol. 120 Issue 5, p707 

    Δ-6 desaturase, also known as fatty acid desaturase-2 (FADS2), is a component of a lipid metabolic pathway that converts the essential fatty acids linoleate and α-linolenate into long-chain polyunsaturated fatty acids. Isolation of Δ-6 desaturase/FADS2 cDNA from human skin predicts an...

  • Expression of interferon-γ in human adrenal gland and kidney tumours. Li, Q.; Zhang, X.-Q.; Nie, L.; Chen, G.-S.; Li, H.; Zhang, F.; Zhang, L.-Y.; Hong, L.; Wang, S.-F.; Wang, H. // British Journal of Cancer;8/6/2007, Vol. 97 Issue 3, p420 

    It is known that interferon-γ (IFN-γ) is produced by activated T and NK lymphoid cells, mononuclear cells, and macrophage and dendritic cells. Our previous studies have shown that IFN-γ-like immunoreactivity also appears in human adrenal cortical tumour and phaeochromocytoma. To...

  • PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Hueber, P.-A.; Waters, P.; Clarke, P.; Eccles, M.; Goodyer, P. // Kidney International;Apr2006, Vol. 69 Issue 7, p1139 

    Renal cell carcinoma (RCC) is the most common kidney malignancy and has a poor prognosis owing to its resistance to chemotherapy. RCC cells overexpress the transcription factor, PAX2, normally expressed in fetal kidney but downregulated at birth. Since Pax2 suppresses apoptosis during renal...

  • Anticancer drugs: A sweet blow for cancer cells. Flight, Monica Hoyos // Nature Reviews Drug Discovery;Oct2011, Vol. 10 Issue 10, p734 

    The article reports on the study published in "Science Translational Medicine" which explores the use of von Hippel-Lindau tumour suppressor (VHL)-deficient renal cell carcinoma (RCC) for synthetic lethal screening. It demonstrates the approach of inhibiting glucose transporter 1 (GLUT1) for...

  • Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. van der Veldt, A. A. M.; Meijerink, M. R.; van den Eertwegh, A. J. M.; Haanen, J. B. A. G.; Boven, E. // British Journal of Cancer;3/2/2010, Vol. 102 Issue 5, p803 

    Background: Because sunitinib can induce extensive necrosis in metastatic renal cell cancer (mRCC), we examined whether criteria defined by Choi might be valuable to predict early sunitinib efficacy.Methods: Computed tomography was used for measurement of tumour lesions...

  • NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. Hosono, T.; Tanaka, T.; Tanji, K.; Nakatani, T.; Kamitani, T. // British Journal of Cancer;3/2/2010, Vol. 102 Issue 5, p873 

    Background:NEDD8 ultimate buster 1 (NUB1) is an interferon (IFN)-inducible protein that downregulates NEDD8 expression and its conjugation system. Although overexpression of NUB1 induces a growth-inhibitory effect in cells, the mechanisms underlying the anti-mitogenic actions of NUB1 in cancer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics